Therefore, our studies indicated that NLRP3 inflammasome activation should be a pivotal mechanism of NEC development; meanwhile, NLRP3 inhibition could offer protective effects on NEC intestinal damage. The gene discussed is NLRP3; the disease is necrotizing enterocolitis.